In Risky Move, Alpharma Launches Generic Neurontin
In a risky move, Alpharma Inc. on Friday launched a generic version of Pfizer's blockbuster epilepsy drug Neurontin without waiting for a court ruling on Pfizer's motion for a preliminary injunction....To view the full article, register now.
Already a subscriber? Click here to view full article